ArticlePubMedPMC 22
The trial will last for 24 weeks, with researchers tracking "changes in drinking, health, and quality of life to determine whether the medication offers a meaningful new treatment option." RELATED: New GLP-1 drugs could suppress desire for more than just food, study suggests Currently, more than 400,000 veterans in the U.S
Lancet 387: 13771396, 2016
The data suggests it may occur, but with how rare these issues are, I would say the benefits generally should outweigh vision risks
Novo Nordisk called it deceptive mass sales under a personalization guise
Wang Y, Zhu J, Liu Z, Shu S, Fu Y, Liu Y, et al